Colorectal Cancer Trial, Recruiting NCT05929820 Sponsor: Cedars-Sinai Medical Center Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT05929820
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are between 45 and 75 years old
  • People who have never been screened for bowel cancer (colorectal cancer), or whose bowel cancer screening is no longer current
  • People who are not considered high risk for bowel cancer (for example, people who do not have inflammatory bowel disease, inherited polyp conditions, or a family history of bowel cancer)
  • People who have never been diagnosed with colon polyps
  • For people joining through an online survey panel called Cint: people who have a scheduled appointment with a primary care doctor within 6 weeks of signing up, and who have a type of health insurance called a Preferred Provider Organization (PPO) plan

Who may not be able to join:

  • People who do not speak English
  • People who do not have access to the internet
  • People whose medical records include certain privacy or research restriction flags (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Christopher V Almario, MD, MSHPM, Cedars-Sinai Medical Center

Phone: 310.423.4462

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Cedars-Sinai Medical Center
Registry
ClinicalTrials.gov
Start date
28 September 2023
Est. completion
22 September 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Rate of completion of a CRC screening test

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov